NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Gadodiamide

Last Revision: February 28, 2019.

Estimated reading time: 1 minute

CASRN: 122795-43-1

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Gadodiamide releases more free gadolinium than some other gadolinium-containing contrast agents. However, guidelines developed by several North American professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium.[1][2][3] Other agents may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

A mother with neuromyelitis optica was nursing her 38-day-old male infant. Each breastfeeding session was about 15 minutes in every 2 hours. She was given gadodiamide (dose not specified) before an MRI scan. She withheld breastfeeding for 6 to 8 hours after the injection. Her infant experienced no immediate adverse effects.[6]

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2017;Version 10.3:102-3. https://www​.acr.org/~​/media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf.
2.
Patenaude Y, Pugash D, Lim K et al. The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can. 2014;36:349-55. [PubMed: 24798674]
3.
Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017;130:e210-e216. [PubMed: 28937575]
4.
Acar S, Keskin-Arslan E, Erol-Coskun H et al. Gadodiamide use during breastfeeding. Reprod Toxicol. 2018;80:59-60. Abstract. DOI: 10.1016/j.reprotox.2018.07.071. [CrossRef]

Substance Identification

Substance Name

Gadodiamide

CAS Registry Number

122795-43-1

Drug Class

  • Breast Feeding
  • Contrast Media
  • Diagnostic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Gadoversetamide[Drugs and Lactation Database (...]
    Review Gadoversetamide
    . Drugs and Lactation Database (LactMed). 2006
  • Review Gadobenate[Drugs and Lactation Database (...]
    Review Gadobenate
    . Drugs and Lactation Database (LactMed). 2006
  • Review Gadoxetate[Drugs and Lactation Database (...]
    Review Gadoxetate
    . Drugs and Lactation Database (LactMed). 2006
  • Review Gadopentetate[Drugs and Lactation Database (...]
    Review Gadopentetate
    . Drugs and Lactation Database (LactMed). 2006
  • Review Ioxaglate[Drugs and Lactation Database (...]
    Review Ioxaglate
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...